1. Home
  2. GLV vs PRE Comparison

GLV vs PRE Comparison

Compare GLV & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLV
  • PRE
  • Stock Information
  • Founded
  • GLV 2004
  • PRE 2014
  • Country
  • GLV United States
  • PRE Hong Kong
  • Employees
  • GLV N/A
  • PRE N/A
  • Industry
  • GLV Finance/Investors Services
  • PRE Biotechnology: Laboratory Analytical Instruments
  • Sector
  • GLV Finance
  • PRE Industrials
  • Exchange
  • GLV Nasdaq
  • PRE Nasdaq
  • Market Cap
  • GLV 72.1M
  • PRE 69.7M
  • IPO Year
  • GLV N/A
  • PRE N/A
  • Fundamental
  • Price
  • GLV $5.59
  • PRE $5.71
  • Analyst Decision
  • GLV
  • PRE Buy
  • Analyst Count
  • GLV 0
  • PRE 1
  • Target Price
  • GLV N/A
  • PRE $9.00
  • AVG Volume (30 Days)
  • GLV 54.2K
  • PRE 10.3K
  • Earning Date
  • GLV 01-01-0001
  • PRE 11-27-2024
  • Dividend Yield
  • GLV 12.44%
  • PRE N/A
  • EPS Growth
  • GLV N/A
  • PRE N/A
  • EPS
  • GLV N/A
  • PRE N/A
  • Revenue
  • GLV N/A
  • PRE $25,561,362.00
  • Revenue This Year
  • GLV N/A
  • PRE $50.97
  • Revenue Next Year
  • GLV N/A
  • PRE $217.53
  • P/E Ratio
  • GLV N/A
  • PRE N/A
  • Revenue Growth
  • GLV N/A
  • PRE N/A
  • 52 Week Low
  • GLV $4.70
  • PRE $2.85
  • 52 Week High
  • GLV $6.06
  • PRE $7.84
  • Technical
  • Relative Strength Index (RSI)
  • GLV 58.18
  • PRE 58.48
  • Support Level
  • GLV $5.35
  • PRE $5.58
  • Resistance Level
  • GLV $5.48
  • PRE $6.00
  • Average True Range (ATR)
  • GLV 0.06
  • PRE 0.28
  • MACD
  • GLV 0.03
  • PRE -0.01
  • Stochastic Oscillator
  • GLV 100.00
  • PRE 92.31

About GLV Clough Global Dividend and Income Fund of beneficial interest

Clough Global Dividend and Income Fund is a closed-ended investment management company. The fund's investment objective is to provide a high level of total return. It invests in equity and debt securities in both U.S. and non-U.S. markets of companies of any market capitalization.

About PRE Prenetics Global Limited

Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.

Share on Social Networks: